The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
The Joint Corp.NASDAQ: JYNT
Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026
Net change in cash declines year over year
Q1 FY2026 net change in cash of $2.88M (cash outflow) fell 7.2% year over year, ahead of the -145.5% change in trailing-twelve-month net change in cash. Sequentially, it fell 55.2% from the prior quarter. Over 3 fiscal years it compounded at -43.4% a year.
Context
- Net change in cash amounted to 3.1% of revenue in FY2025, down 9.9 pp from a year earlier.
- Net change in cash increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -7.2% holds above the trailing-twelve-month pace of -145.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- (1.69M) USD
- Year-over-year change
- -125.0%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.69M) | -125.0% |
| FY2024 | 2024-12-31 | 6.78M | -21.7% |
| FY2023 | 2023-12-31 | 8.66M | +192.5% |
| FY2022 | 2022-12-31 | (9.36M) | -931.9% |
| FY2021 | 2021-12-31 | (907.29K) | — |
Net Change in Cash vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's LTM Mar 2026 net change in cash of $1.47M is the 8th largest of the 11 companies compared; the peer median is $2M.
- Its year-over-year change of -145.5% is the 8th highest of 11, against a peer median of -49.4%.
- Net change in cash amounts to 2.6% of revenue for JYNT, versus a peer median of 35.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $5.67T | -12837118.8% | +54.1% | 1879098.5% | |
| LTM Mar 2026 | $36.38M | -1.9% | — | 19.3% | |
| LTM Mar 2026 | $23.87M | -133.6% | — | — | |
| LTM Mar 2026 | $14.8M | +181.1% | — | — | |
| LTM Mar 2026 | $5.09M | +47.7% | — | 14.8% | |
| LTM Mar 2026 | $2.95M | -210.6% | — | 2.4% | |
| LTM Mar 2026 | $2.64M | +462.5% | — | 51.4% | |
| LTM Mar 2026 | $1.47M | -145.5% | -43.4% | 2.6% | |
| LTM Mar 2026 | $1.06M | -206.5% | -85.0% | 1850.9% | |
| LTM Mar 2026 | $336.9K | -96.9% | +51.6% | 84.9% | |
| LTM Mar 2026 | $126K | +102.0% | -96.4% | 0.2% | |
| Peer median (excluding JYNT) | $2M | -49.4% | -16.7% | 35.4% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 7.57M | 626.71K | (9.75M) | (8.53M) | 2.91M |
| Depreciation & Amortization | 3.92M | 6.65M | 8.58M | 4.72M | 1.71M |
| Deferred Income Tax | (1.78M) | (441.35K) | 10.9M | (55.56K) | 93.07K |
| Stock-Based Compensation | 1.06M | 1.27M | 1.74M | 1.68M | 1.3M |
| Change in Working Capital | 3.09M | (238.06K) | 798.62K | 1.1M | (9.56M) |
| Accounts Receivables | (1.64M) | (154.67K) | 192.35K | (1.65M) | 1.53M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (14.37K) | 818.27K | (1.38M) | 68.26K | (391.13K) |
| Other Working Capital | 4.74M | (901.65K) | 1.99M | 2.68M | (10.7M) |
| Other Non-Cash Items | (7.77K) | 341.68K | 2.41M | 10.5M | 5.39M |
| Operating Cash Flow | 13.84M | 8.21M | 14.68M | 9.42M | 1.84M |
| Capital Expenditures | (6.99M) | (5.9M) | (5M) | (1.19M) | (1.5M) |
| Acquisitions (Net) | (5.77M) | (12.11M) | (1.19M) | 554.1K | 7.78M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 105.2K | 0 | 0 | 0 |
| Investing Cash Flow | (12.75M) | (17.9M) | (6.19M) | (631.55K) | 6.27M |
| Debt Repayment | (2.81M) | (49.86K) | (24.43K) | (2.03M) | (4.35K) |
| Common Stock Issued | 0 | 0 | 202.39K | 33.71K | 1.52M |
| Common Stock Repurchased | 0 | (5.8K) | (3.83K) | (9.58K) | (11.32M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 811.59K | 384.27K | 0 | 0 | 0 |
| Financing Cash Flow | (2M) | 328.61K | 174.12K | (2M) | (9.81M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (907.29K) | (9.36M) | 8.66M | 6.78M | (1.69M) |
| Free Cash Flow | 6.85M | 2.31M | 9.68M | 8.23M | 334.72K |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.